07 October 2024
07 October 2024
The Phase I trial assessed the safety profile of GE Healthcare’s injectable manganese MRI contrast agent in healthy volunteers.
The study conducted by Medscape similarly found that whilst 51% of doctors are enthusiastic about the tech, many view it with serious apprehension.
The investment is aimed at enhancing the US’ readiness for potential future public health crises.
The systems are designed to streamline the scanning process for better-quality outcomes.
The stent incorporates a drug-release mechanism that enables delivery of a 'limus' medication throughout peripheral arteries.
The device is designed to outperform conventional implants, minimising issues and boosting patient recovery.
The device is used to visualise the placement of hip components during total hip arthroplasty surgery.
The UK's Presymptom Health was borne out of an MoD study with a view to commercialising AI-based infection research.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
GlobalData's latest report provides comprehensive information about the Blood Pressure Monitors pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report will enable you to access significant competitor information, analysis, and insights to improve your R&D strategies, and identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage.
Give your business an edge with our leading industry insights.
